Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomx Therapeutics IncfiledCriticalCytomx Therapeutics Inc
Priority claimed from PCT/US2016/030785external-prioritypatent/WO2016179285A1/en
Publication of MY193448ApublicationCriticalpatent/MY193448A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. (Fig.1)
MYPI2017001623A2015-05-042016-05-04Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof
MY193448A
(en)
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same